In this study, we report the ability of Met to enrich human lung cancer cells expressing higher levels of wild type EGFR (EGFRhigh) and enhance their sensitivity to the therapeutic effect of the TKR inhibitor, Erlo. This evidence concerns the gene EGFR and lung carcinoma.